Anti-Aging Supplements Linked to Increased Cancer Resilience in New Study
The booming market for anti-aging and longevity supplements, where Americans spend millions annually, faces a stark warning from new scientific research. Popular vitamin B3 derivatives—including nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), and nicotinamide (NAM)—are under scrutiny for potentially harming health in cancer patients rather than improving it.
NAD+ Supplements: A Double-Edged Sword in Cancer Treatment
These supplements are widely touted for their ability to raise levels of NAD+, a crucial molecule involved in metabolism and cellular repair. Early studies suggest that boosting NAD+ can supply cells with additional fuel, potentially supporting energy, brain and heart health, and slowing aging processes. However, a groundbreaking study from Case Western Reserve University School of Medicine reveals a concerning flip side.
Published in the journal Cancer Letters, the research indicates that while NAD+ floods healthy cells with beneficial fuel, in cancer patients, malignant cells can hijack this energy source. This hijacking allows cancer cells to power up their energy systems, repair chemotherapy-induced damage, and evade programmed cell death. Consequently, tumors become more likely to survive doses of chemotherapy that would typically eradicate the disease.
Pancreatic Cancer: A Critical Context for Concern
The study focused on pancreatic cancer, a particularly aggressive disease with a five-year survival rate of only about 20 percent. Diagnoses have been rising among younger Americans, with increases of 4.3 percent annually in ages 15-34 and 1.5 percent in ages 35-54 between 2000 and 2021, according to a 2025 analysis. Pancreatic cancer is often diagnosed at advanced stages due to subtle symptoms like abdominal pain, pale stools, and unexplained weight loss, making treatment challenging.
Researchers found that NAD+-boosting supplements, especially NMN, protected pancreatic cancer cells from three common chemotherapy drugs. They strengthened tumors by enhancing cancer cell energy, reducing oxidative stress (a key mechanism chemotherapy uses to kill cells), and suppressing DNA damage and cell death. This triple effect could render pancreatic cancer even more difficult to treat effectively.
Expert Warnings and Calls for Action
Jordan Winter, study author and co-leader of the Case Comprehensive Cancer Center, emphasized the gravity of the findings. "Our discoveries highlight a potentially concerning role for NAD+-boosting supplements in the context of an active cancer, especially when used alongside chemotherapy," he stated. "This research is a critical reminder that 'natural' doesn’t always mean safe, particularly in the complex biology of cancer treatment."
The researchers stress that their results do not imply these supplements are dangerous for healthy individuals. However, for active cancer patients undergoing chemotherapy, the risks are serious and demand immediate attention. They advocate for screening cancer patients for supplement use and further investigation into interactions between NAD+ supplements and cancer therapies.
The Supplement Market and Celebrity Endorsements
NMN, NR, NAM, and standalone NAD+ are readily available over-the-counter, typically in pill or capsule form, with prices ranging from $18 to over $100. High-profile figures have popularized these products; for instance, longevity guru Bryan Johnson sells a "longevity mix" powder containing a vitamin B complex and NR for $98, while supermodel Kendall Jenner has discussed receiving NAD+ infusions as part of her wellness routine.
Previous research has suggested benefits from NAD+ supplements, such as improvements in energy, cognition, and metabolic health. Yet, the new study underscores the need for caution, particularly among those with cancer. Winter advises that cancer patients should thoroughly discuss supplement risks with their doctors and medical teams to avoid unintended consequences during treatment.
As the anti-aging supplement industry continues to grow, this study serves as a pivotal call to action for both the medical community and consumers to prioritize safety and evidence-based practices in the pursuit of longevity.
